Algiax Pharmaceuticals

📍 Erkrath, Germany🗓 Founded 2011👥 4 employees💰 Last funded Jul 2022
Pharmaceutical Manufacturing🌐 algiax.com
Website LinkedIn
Algiax Pharmaceuticals GmbH is an independent biotechnology company that was established in April 2011. It is dedicated to the discovery and development of innovative products to treat diseases with a high unmet medical need. In the field of nervous system disease, Algiax has a strong focus on neuropathic pain and acute spinal cord injury. Algiax’ lead candidate AP-325 is in clinical development for the treatment of neuropathic pain. A selection of new chemical entities (AP-4 & AP-8) is in preclinical development for the treatment of Diabetes Type 1. Algiax’ strategy is to develop its drug candidates up to a Clinical Phase II-III stage and out-license them to pharmaceutical and biotech companies for further clinical development and market authorisation.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Algiax Pharmaceuticals?
Algiax Pharmaceuticals has 1 investors on record on gritt.io.
When did Algiax Pharmaceuticals last raise funding?
The most recent investment in Algiax Pharmaceuticals recorded on gritt.io was in July 2022.
When was Algiax Pharmaceuticals founded?
Algiax Pharmaceuticals was founded in 2011.
What industry is Algiax Pharmaceuticals in?
Algiax Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Algiax Pharmaceuticals based?
Algiax Pharmaceuticals is headquartered in Erkrath, Germany.